Background and Purpose—The authors present an overview of the current evidence and
management recommendations for evaluation and treatment of adults with acute ischemic …

Background Randomized controlled clinical trials (RCT) have demonstrated varied efficacy
of glucagon-like peptide-1 receptor (GLP-1R) agonists for cardiovascular outcomes. We …

Acute ischaemic stroke (AIS) is a leading cause of death and disability worldwide. Its
incidence and prevalence increase considerably with age and numbers will grow with an …

Diabetes is a common comorbidity in stroke patients and a strong predictor of poor
functional outcome. To provide a more mechanistic understanding of this clinically relevant …

Background Little is known about the prognostic role of fasting glucose after mechanical
thrombectomy (MT). Aims We investigated whether fasting glucose on the next day after MT …

In the outpatient setting, glucagon‐like peptide‐1 (GLP‐1) receptor agonists have proved to
be highly efficacious drugs that provide glycaemic control with a low risk of hypoglycaemia …

IntroductionPrehospital first responders historically have treated hypoglycemia in the field
with an IV bolus of 50 mL of 50% dextrose solution (D50). The California Contra Costa …

Admission hyperglycemia (HG) amplifies vascular injury and neurological deficits in acute
ischemic stroke, but the mechanisms remain controversial. We recently reported that …

Abstract Purpose of Review Hyperglycemia occurs frequently in hospitalized patients with
stroke and peripheral vascular disease (PVD). Guidelines for inpatient glycemic …

Introduction: Prehospital first responders historically have used an IV bolus of 50 mL of 50%
dextrose solution (D50) for the treatment of hypoglycemia in the field. A local Emergency …